We Focus on Identifying, Acquiring and Developing Disease Modifying Therapeutic Drug Candidates with a Concentration on Rare Disease Indications

At Curative Biotech, our unique business model coupled with our deep industry leadership experience enables us to build a pipeline of first in class drugs with accelerated development pathways to address the unmet medical needs of patients.


We currently have development assets in three therapeutic areas:

Our programs are currently focused on orphan indications; however, the mechanisms of action we are targeting will likely allow us to expand the use of these drugs in the future to non-orphan indications.

Degenerative Eye Disease

Neuro Oncology

Infectious Disease


CUBT Stock Price

*Quotes on stock price are delayed and not real-time.